Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for cancer therapy.
about
New Modalities for Challenging Targets in Drug Discovery.Cyclotides: Overview and Biotechnological Applications.Cyclotides, a versatile ultrastable micro-protein scaffold for biotechnological applications.An engineered cyclic peptide alleviates symptoms of inflammation in a murine model of inflammatory bowel disease.
P2860
Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for cancer therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dual-targeting anti-angiogenic ...... drug leads for cancer therapy.
@en
Dual-targeting anti-angiogenic ...... drug leads for cancer therapy.
@nl
type
label
Dual-targeting anti-angiogenic ...... drug leads for cancer therapy.
@en
Dual-targeting anti-angiogenic ...... drug leads for cancer therapy.
@nl
prefLabel
Dual-targeting anti-angiogenic ...... drug leads for cancer therapy.
@en
Dual-targeting anti-angiogenic ...... drug leads for cancer therapy.
@nl
P2860
P50
P356
P1433
P1476
Dual-targeting anti-angiogenic ...... drug leads for cancer therapy.
@en
P2860
P2888
P356
10.1038/SREP35347
P407
P577
2016-10-13T00:00:00Z